The company is demonstrably boosted this course of the novel therapy for ATTR-CM, leveraging the compound. Initial patient data reveals promising outcomes for patients diagnosed with a severe condition. This emphasis highlights researchers’ focus to managing unmet medical demands in this cardiology arena. Attruby: BridgeBio's Novel Appr… Read More